Novel Coronavirus (SARS-CoV-2/COVID-19)
Providing the Continuum of Outpatient Behavioral Health Services during COVID-19
Lessons from Sheppard Pratt Health System, Baltimore
he Centers for Medicare & Medicaid Services April 28 and April 30 will host calls for hospitals, health systems and providers on COVID-19.
The novel coronavirus is reshaping health care through technology. Recent advances, such as artificial intelligence, telehealth, virtual collaboration and data tracking are instrumental in addressing the virus and flattening the curve.
A coalition led by the American Hospital Association, the U.S. Chamber of Commerce and America’s Health Insurance Plans (AHIP), and comprising nearly 30 other organizations, sent a letter to Congress urging swift action to protect Americans’ health care coverage in its response to the COVID-19…
A coalition led by the American Hospital Association, the U.S. Chamber of Commerce and America’s Health Insurance Plans (AHIP), and comprising nearly 30 other organizations, sent a letter to Congress urging swift action to protect Americans’ health care coverage in its response to the COVID-19…
AHA expresses concern with the distribution of the Public Health and Social Services Emergency Fund, which has left many hospitals and health systems on the front lines with limited resources to serve their communities.
As hospitals and health systems continue to respond to the COVID-19 pandemic, the financial impact has been significant. Please join representatives from Fitch, Moody's and Standard & Poor's for an AHA Town Hall April 29 at 1 p.m. ET on hospital credit ratings amid the pandemic.
The Food and Drug Administration April 24 reminded health care providers of the need to closely monitor patients for serious and potentially life-threatening side effects of hydroxychloroquine and chloroquine when used off-label to treat COVID-19.
The AHA has been featured in numerous media publications, including the Washington Post, Wall Street Journal, Politico and Modern Healthcare, for various COVID-19 content.
The Centers for Medicare & Medicaid Services recently announced a six-month delay in implementation of its Innovation Center Maternal Opioid Misuse (MOM) Model, due to COVID-19.